BoneSupport

60 articles about BoneSupport

• BONESUPPORT Appoints Michael Roth as General Manager & Executive Vice President Commercial Operations North America

  4/29/2020

  BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries announces a change in its leadership team that will take place June 1, 2020.

• Accelerated Road to Market Approval for CERAMENT® G in the US - BONESUPPORTTM Submits De Novo Application

  3/23/2020

  BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, announced that the company will submit a De Novo application to the US Food and Drug Administration to obtain a market approval for the company's antibiotic-releasing product CERAMENT G.

• BoneSupport Achieves Aim of Recruiting 136 Patients Into the CERTiFy Study Comparing Cerament|Bone Void Filler With Autograft

  12/13/2017

  The primary outcome of the study is based on data from the SF-12 Physical Component Summary, which assesses the patient’s physical functioning, at week 26.

• BoneSupport Preps for $62 Million IPO

  6/15/2017

• BoneSupport Announces First Patient Enrolled In FORTIFY Trial With CERAMENT |G, A Novel Injectable, Antibiotic-Eluting Bone Graft Substitute

  5/23/2017

• BoneSupport Announces First Patient Enrolled In FORTIFY Trial With CERAMENT G, A Novel Injectable, Antibiotic-Eluting Bone Graft Substitute

  5/22/2017

• Lennart Johansson To Join BoneSupport Board of Directors

  4/28/2017

• Lennart Johansson To Join BoneSupport Board Of Directors

  4/28/2017

• BoneSupport Founder Lars Lidgren Receives The 2017 OREF Clinical Research Kappa Delta Award

  3/16/2017

• Björn Westberg To Join BoneSupport As Chief Financial Officer

  12/21/2016

• BoneSupport Confirms Election Of Dr. Håkan Björklund As Chairman Of The Board

  12/19/2016

• BoneSupport Confirms Election Of Dr. Håkan Björklund As Chairman Of The Board

  12/16/2016

• BoneSupport Announces Key Corporate Appointment To Drive Growth In North America

  11/7/2016

• BoneSupport Nabs $37 Million

  10/27/2016

• BoneSupport‘s CERAMENT|G Highly Effective Adjunct In The Single Stage Surgical Management Of Chronic Osteomyelitis – Results From Prospective Study Of 100 Patients Published In The Bone And Joint Journal

  9/1/2016

• BoneSupport‘s CERAMENT|G And CERAMENT V To Be Featured Extensively At The 35th Annual Meeting Of The European Bone & Joint Infection Society (EBJIS) In Oxford, UK

  8/30/2016

• BoneSupport Receives FDA Approval To Initiate IDE Clinical Study

  8/9/2016

• BoneSupport Announces Nature Publication Of Pre-Clinical Study Highlighting CERAMENT'S Attractive Bone Remodeling Properties And As A Local Drug Delivery Platform For Bone Disease

  6/1/2016

• BoneSupport Announces Availability In Europe Of CERAMENT|G In 5 mL Volume To Address Growing Market Demand

  3/1/2016

• BoneSupport Reports Expansion Of Company's CERAMENT Drug Eluting Procedure Registry

  2/2/2016